Search for the latest oncology news by tumour type
AACR 2018: Effect of prostate cancer gene can go either way
Roswell Park Comprehensive Cancer Center researchers have found that the effect of a key gene…
Browsing: Tumour Stream
AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable lung cancer
The anti-PD1 immunotherapy nivolumab given prior to surgical resection of stage 1-3 non-small cell lung…
AACR 2018: Combination therapy doubles survival in metastatic lung cancer
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small…
AACR 2018: Precancerous colon polyps in patients with Lynch syndrome exhibit immune activation
Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk,…
AACR 2018: Updated OS data for olaparib in gBRCA-Mutated HER2 negative metastatic breast cancer
Data from the Phase III OlympiAD trial, showing the final overall survival (OS) results for…
Scientists uncover 80 potential lines of attack against prostate cancer
Scientists have identified 80 molecular weaknesses in prostate cancer that could be targeted by drugs…
Mouse study links early metastasis to systemic inflammation caused by wound healing
According to new research conducted in mice by Whitehead Institute scientists, surgery in breast cancer…
How tumour donations from patients help scientists understand cancer
“You don’t exactly want your tumour to take home and stick on your mantelpiece -…
AACR 2018: Pembrolizumab reduced the risk for recurrence of stage 3 melanoma
A one-year course of 18 doses of pembrolizumab significantly reduced the risk of recurrence for…
Selective internal radiation therapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort
The final results of the palliative cohort of the SORAMIC study in patients with unresectable,…